Insulet Corp

PODD: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|l%LOCK|KBNPHLOCK|r$TbcLs

Insulet Earnings: Strong Start to 2026, but Higher Guidance May Have Disappointed

Insulet reported first-quarter results that featured constant-currency revenue growth of 30% and adjusted earnings growth of 29%. Management raised its outlook for 2026 revenue growth and operating margin by 100 basis points at the midpoint.

Sponsor Center